Oncology and Hematology
145-160 of 651
Giuseppe Curigliano, MD, PhD
- MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
1.00 program creditKomal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
- MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
- MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
1.00 program creditGiuseppe Curigliano, MD, PhD
Alexandria May, PharmD, BCPS
Angela Waanders, MD, MPH, MS
Ashley S. Margol, MD, MS
Vinod Pullarkat, MD
Jennifer Caudle, DO, FACOFP
Catherine Broome, MD
Brian P. McDonough, MD, FAAFP
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Charles Turck, PharmD, BCPS, BCCCP
Timothy Kubal, MD
Charles Turck, PharmD, BCPS, BCCCP
Jamie Koprivnikar, MD
Abdulraheem Yacoub, MD
